Scientists generated modified MSCs by IVT mRNA transfection to overexpress granulocyte-macrophage colony-stimulating factor and determine their therapeutic effect alone or in combination with doxorubicin in a murine model of hepatocellular carcinoma.
[Current Stem Cell Research & Therapy]